We focus on the economic balance and the social and environmental impact of our activities
Commitment, reliability and sustainability characterize ESTEVE´s relationships with partners and guarantee outstanding results
EISAI AND ESTEVE SIGN NEW AGREEMENT TO CO-PROMOTE ANTI-EPILEPSY DRUG FYCOMPA® (PERAMPANEL) IN SPAIN
02/02/2016 - Eisai and Esteve will launch the new indication for the adjunctive treatment of primary generalised tonic-clonic (PGTC) seizures in adults and adolescents (≥12 years) with idiopathic generalised epilepsy (IGE...
» Go to Press Room